Safety and Efficacy of NA-931 and Tirzepatide in Adults Who Are Overweight or Obese
Public ClinicalTrials.gov record NCT06732245. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-Blind, Placebo-Controlled Multi-Center Study of Oral NA-931, Alone or in Addition to Open Label Subcutaneous Tirzepatide , to Investigate the Efficacy and Safety in Overweight or Obese Men and Women
Study identification
- NCT ID
- NCT06732245
- Recruitment status
- Not yet recruiting
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Biomed Industries, Inc.
- Industry
- Enrollment
- 224 participants
Conditions and interventions
Conditions
Interventions
- NA-931 Drug
- NA-931 150 mg + no Tirzepatide Drug
- Tirzepatide Drug
Drug
Eligibility (public fields only)
- Age range
- 19 Years to 80 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 14, 2026
- Primary completion
- Aug 14, 2027
- Completion
- Dec 14, 2027
- Last update posted
- Mar 26, 2026
2026 – 2027
United States locations
- U.S. sites
- 8
- U.S. states
- 4
- U.S. cities
- 8
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Biomed Research Unit #90067-102 | Los Angeles | California | 90067 | — |
| Biomed Research Unit # 92121-103 | San Diego | California | 92121 | — |
| Biomed Research Unit # 94104-101 | San Francisco | California | 94104 | — |
| Biomed Research Unit # 33012-104 | Hialeah | Florida | 33012 | — |
| Biomed Research Unit # 32256-105 | Jacksonville | Florida | 32256 | — |
| Biomed Research Unit # 33461-106 | Lake Worth | Florida | 33461 | — |
| Biomed Research Unit # 10021-107 | New York | New York | 10021 | — |
| Biomed Research Unit # 77479-108 | Sugar Land | Texas | 77479 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 9 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06732245, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 26, 2026 · Synced May 6, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06732245 live on ClinicalTrials.gov.